Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4519121000168116 | Kabiven G19% Intralipid (soya oil 100 g / 2.566 L) injection, 500 mL chamber (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4519131000168118 | Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | Is a | Kabiven G19% Intralipid | true | Inferred relationship | Some | ||
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | Is a | soya oil 100 g/2.566 L injection, 500 mL chamber | true | Inferred relationship | Some | ||
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | has Australian BoSS | soya oil | true | Inferred relationship | Some | 434459085 | |
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | has intended active ingredient | soya oil | true | Inferred relationship | Some | 434459085 | |
Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber | has unit of use | chamber | true | Inferred relationship | Some | 2117495086 |
Reference Sets
Trade product unit of use reference set